Literature DB >> 32338871

Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma.

Alba Nicolás-Boluda1,2, Javier Vaquero3,4,5, Gautier Laurent6, Gilles Renault2, Rana Bazzi6, Emmanuel Donnadieu2, Stéphane Roux6, Laura Fouassier3, Florence Gazeau1.   

Abstract

Physical oncology recognizes tissue stiffness mediated by activation of cancer-associated fibroblasts (CAF) and extracellular matrix remodeling as an active modulator of tumorigenesis, treatment resistance, and clinical outcome. Cholangiocarcinoma (CCA) is a highly aggressive and chemoresistant desmoplastic cancer enriched in CAF. CCA's stroma mechanical properties are considered responsible for its chemoresistant character. To normalize tumor mechanics, we propose a physical strategy based on remotely light-activated nanohyperthermia to modulate the tumor microenvironment. In this study, we report the use of multifunctional iron oxide nanoflowers decorated with gold nanoparticles (GIONF) as efficient nanoheaters to achieve complete tumor regression following three sessions of mild hyperthermia. The preferential uptake of GIONF by CAF allowed targeting this cell population, which resulted in a significant early reduction of tumor stiffness followed by tumor regression. In conclusion, our study highlights a spatially and temporally controlled physical strategy, GIONF-mediated photothermal therapy to deplete CAF and normalize the tumor mechanics that may apply to desmoplastic cancer and CCA treatment.

Entities:  

Keywords:  cancer-associated fibroblast; cholangiocarcinoma; iron oxide nanoflowers; photothermal therapy; stiffness

Mesh:

Substances:

Year:  2020        PMID: 32338871     DOI: 10.1021/acsnano.0c00417

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  15 in total

1.  Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts.

Authors:  Xin Li; Tuying Yong; Zhaohan Wei; Nana Bie; Xiaoqiong Zhang; Guiting Zhan; Jianye Li; Jiaqi Qin; Jingjing Yu; Bixiang Zhang; Lu Gan; Xiangliang Yang
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

2.  Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Authors:  Juan Wang; Emilien Loeuillard; Gregory J Gores; Sumera I Ilyas
Journal:  Expert Opin Ther Targets       Date:  2021-12-03       Impact factor: 6.797

Review 3.  Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma.

Authors:  Thomas Lambin; Cyril Lafon; Robert Andrew Drainville; Mathieu Pioche; Frédéric Prat
Journal:  World J Gastroenterol       Date:  2022-04-07       Impact factor: 5.374

Review 4.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

Review 5.  Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment.

Authors:  Debolina Ganguly; Raghav Chandra; John Karalis; Martha Teke; Todd Aguilera; Ravikanth Maddipati; Megan B Wachsmann; Dario Ghersi; Giulia Siravegna; Herbert J Zeh; Rolf Brekken; David T Ting; Matteo Ligorio
Journal:  Cancers (Basel)       Date:  2020-09-17       Impact factor: 6.575

Review 6.  Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.

Authors:  Mengping Liu; Lin Wang; Young Lo; Simon Chi-Chin Shiu; Andrew B Kinghorn; Julian A Tanner
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

Review 7.  Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.

Authors:  Parniyan Maneshi; James Mason; Mitesh Dongre; Daniel Öhlund
Journal:  Front Cell Dev Biol       Date:  2021-11-25

8.  MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.

Authors:  Renjie Yang; Dong Wang; Shen Han; Yichao Gu; Zhi Li; Lei Deng; Aihong Yin; Yun Gao; Xiangcheng Li; Yue Yu; Xuehao Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 10.750

9.  NIR-Absorbing Mesoporous Silica-Coated Copper Sulphide Nanostructures for Light-to-Thermal Energy Conversion.

Authors:  Elisabetta Fanizza; Rita Mastrogiacomo; Orietta Pugliese; Alexa Guglielmelli; Luciano De Sio; Rachele Castaldo; Maria Principia Scavo; Mariangela Giancaspro; Federica Rizzi; Gennaro Gentile; Fabio Vischio; Livianna Carrieri; Ilaria De Pasquale; Giacomo Mandriota; Francesca Petronella; Chiara Ingrosso; Marino Lavorgna; Roberto Comparelli; Marinella Striccoli; Maria Lucia Curri; Nicoletta Depalo
Journal:  Nanomaterials (Basel)       Date:  2022-07-24       Impact factor: 5.719

Review 10.  Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.

Authors:  Pradip De; Jennifer Aske; Raed Sulaiman; Nandini Dey
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.